Psyence Group Inc. entered into a partnership with Eden Labs LLC. The partnership features a Global IP Licensing Agreement for the commercialization by Psyence of extraction technology and formulation IP developed by Eden Labs for the production of a water soluble, doseable, stabilized psilocybin powder naturally derived from the fruiting bodies of psilocybin-yielding mushrooms cultivated and processed at Psyence's federally licensed certified facility in Southern Africa. The partnership will be facilitated by South African entrepreneur Cody Futeran who will play an active role in the business development arm of the venture.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | +20.00% | 0.00% | -40.00% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.00% | 3.06M | |
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- PSYG Stock
- News Psyence Group Inc.
- Psyence Group Inc. and Eden Labs LLC Announces Extraction and Product Development Collaboration